查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1810975

2025年新一代體外診斷（IVD）全球市場報告

Next-Generation In Vitro Diagnostics (IVD) Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計下一代體外診斷 (IVD) 市場將在未來幾年強勁成長，到 2029 年將達到 1,720.2 億美元，年複合成長率（CAGR）為 9.9%。預測期內的成長歸因於個人化醫療的進步、醫療保健支出的增加、研發活動的活性化、感染疾病病率的上升以及慢性疾病患者的激增。預測期內的主要趨勢包括技術創新、人工智慧和機器學習在診斷中的應用、先進診斷技術的進步、個人化醫療以及新型生物標記的發現。

個人化醫療需求的不斷成長預計將在未來幾年推動下一代體外診斷 (IVD) 市場的成長。個人化醫療是一種根據個人基因圖譜、環境和生活方式來客製化疾病預防和治療方案的醫療保健方法。個人化醫療的成長得益於基因組數據的日益普及，這使得醫療保健提供者能夠根據個人獨特的基因組成開發標靶治療，從而獲得更有效的治療方案。下一代體外診斷 (IVD) 透過提供準確的分子和遺傳資訊來支持個人化醫療，為每位患者制定個人化的治療和預防策略。例如，2024 年 2 月，美國醫院和醫療保健組織個人化醫療聯盟 (Personalized Medicine Coalition) 報告稱，FDA 在 2023 年核准了16 種針對罕見疾病患者的新型個人化療法，高於 2022 年的 6 種。因此，個人化醫療需求的不斷成長正在推動下一代體外診斷 (IVD) 市場的擴張。

下一代體外診斷（IVD）市場的關鍵參與者正在建立策略夥伴關係關係，與技術提供者、研究機構和醫療保健組織合作，以加速創新，提高診斷準確性，並擴大個人、企業和政府獲得先進檢測解決方案的管道。策略夥伴關係關係使公司能夠利用彼此的優勢和資源，實現互利通用。例如，2024 年 10 月，英國生技公司 Yourgene Health 與哥倫比亞人類基因診斷公司 Genetix 合作，推出了哥倫比亞首個本地可用的非侵入性產前檢測 (NIPT) 服務。這項舉措標誌著該地區產前檢測的重大進步，為準父母提供了更快、更可靠、更具成本效益的先進基因篩檢。該服務採用 Yourgene Health 的 IONA Nx NIPT 工作流程，這是一種獲得 CE 標誌認證的綜合體外診斷 (IVD) 解決方案。此工作流程靈活且擴充性，可適應各種樣本量，使 Genetix 能夠在整個哥倫比亞提供品質有保證的產前篩檢服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球新一代體外診斷（IVD）：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球新一代體外診斷（IVD）市場：成長率分析
  • 全球下一代體外診斷 (IVD) 市場表現：規模與成長，2019-2024 年
  • 全球新一代體外診斷 (IVD) 市場預測：2024-2029 年及 2034 年規模與成長
  • 全球新一代體外診斷（IVD）：總目標市場（TAM）

第6章市場區隔

  • 全球新一代體外診斷 (IVD) 市場：按產品類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 耗材
  • 裝置
  • 軟體
  • 全球下一代體外診斷 (IVD) 市場：按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 核心實驗室診斷
  • 就地檢驗
  • 分子診斷
  • 全球新一代體外診斷 (IVD) 市場：按應用、效能和預測，2019-2024 年、2024-2029 年、2034 年
  • 腫瘤學或癌症
  • 感染疾病
  • 糖尿病
  • 心臟病學
  • 其他用途
  • 全球下一代體外診斷 (IVD) 市場：按最終用戶、績效和預測，2019-2024 年、2024-2029 年、2034 年
  • 醫院和診所
  • 診斷實驗室
  • 學術研究機構
  • 其他最終用戶
  • 全球新一代體外診斷 (IVD) 市場：按耗材 (類型)、性能和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 條碼標籤
  • 無線射頻識別標籤
  • 檢體袋和管
  • 標籤色帶
  • 密封件和蓋子
  • 全球新一代體外診斷 (IVD) 市場：按設備類型、實際和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 條碼掃描器
  • 射頻識別讀取器
  • 標籤印表機
  • 工作站和終端
  • 儲運監控設備
  • 全球新一代體外診斷 (IVD) 市場：按軟體類型、效能和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 實驗室資訊管理系統
  • 樣本追蹤軟體模組
  • 雲端基礎的追蹤軟體
  • 條碼和無線射頻識別（RFID）整合平台
  • 檢體追蹤的行動應用程式

第7章 區域和國家分析

  • 全球新一代體外診斷 (IVD) 市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球下一代體外診斷 (IVD) 市場：按國家/地區、績效及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章：俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 下一代體外診斷（IVD）市場：競爭格局
  • 下一代體外診斷（IVD）市場：公司簡介
    • F Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Grifols SA
  • Agilent Technologies Inc.
  • Illumina Inc.
  • Sysmex Corporation
  • Bio-Rad Laboratories Inc.
  • Revvity Inc.
  • Exact Sciences Corporation
  • QIAGEN NV
  • DiaSorin SpA
  • Singular Genomics Systems Inc.
  • Guardant Health Inc.
  • Pacific Biosciences of California Inc.
  • Transasia Bio-Medicals Ltd.
  • Athena Dx
  • J Mitra and Co Pvt Ltd

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029 年新一代體外診斷 (IVD) 市場：提供新機會的國家
  • 2029年新一代體外診斷（IVD）市場：細分市場帶來新機會
  • 2029年下一代體外診斷（IVD）市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第36章 附錄

簡介目錄
Product Code: r37077

Next-generation in vitro diagnostics (IVD) refers to advanced diagnostic tools and technologies that examine biological samples-such as blood, saliva, or tissue-outside the body to identify diseases, conditions, or infections with enhanced accuracy, speed, and personalization. These technologies often incorporate innovations like genomics, artificial intelligence, digital health platforms, and high-throughput sequencing. The main goal of next-generation IVD is to facilitate earlier, more precise, and patient-tailored diagnosis and monitoring of diseases, including cancer, infectious diseases, and genetic disorders.

The primary product categories in next-generation in vitro diagnostics (IVD) include consumables, instruments, software, and others. Core laboratory diagnostics involve centralized testing services that process a wide variety of biological samples using automated, high-throughput instruments and assays. This encompasses types such as core laboratory diagnostics, point-of-care testing, and molecular diagnostics. These tools are applied across various fields, including oncology, infectious diseases, diabetes, cardiology, and other diagnostic areas, serving a diverse range of end users like hospitals and clinics, diagnostic laboratories, academic and research institutions, and other healthcare providers.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The next-generation in vitro diagnostics (IVD) market research report is one of a series of new reports from The Business Research Company that provides next-generation in vitro diagnostics (IVD) market statistics, including next-generation in vitro diagnostics (IVD) industry global market size, regional shares, competitors with a next-generation in vitro diagnostics (IVD) market share, detailed next-generation in vitro diagnostics (IVD) market segments, market trends and opportunities, and any further data you may need to thrive in the next-generation in vitro diagnostics (IVD) industry. This next-generation in vitro diagnostics (IVD) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The next-generation in vitro diagnostics (IVD) market size has grown rapidly in recent years. It will grow from $106.97 billion in 2024 to $117.97 billion in 2025 at a compound annual growth rate (CAGR) of 10.3%. The growth in the historic period can be attributed to the growing geriatric population, increased government funding, escalating investments in genomic research, expansion in clinical trials, and greater consumer health awareness.

The next-generation in vitro diagnostics (IVD) market size is expected to see strong growth in the next few years. It will grow to $172.02 billion in 2029 at a compound annual growth rate (CAGR) of 9.9%. The growth in the forecast period can be credited to the expanding advancement of personalized medicine, rising healthcare expenditures, increasing research and development activities, growing incidence of infectious diseases, and a surge in chronic disease cases. Key trends during the forecast period include technological innovations, the incorporation of artificial intelligence and machine learning in diagnostics, progress in advanced diagnostic technologies, personalized medicine, and the discovery of novel biomarkers.

The rising demand for personalized medicine is expected to drive the growth of the next-generation in vitro diagnostics (IVD) market moving forward. Precision medicine is a healthcare approach that tailors disease prevention and treatment based on an individual's genetic profile, environment, and lifestyle. The growth of personalized medicine is fueled by the increasing availability of genomic data, enabling healthcare providers to develop targeted treatments based on a person's unique genetic makeup, resulting in more effective care. Next-generation in vitro diagnostics (IVD) supports personalized medicine by delivering precise molecular and genetic insights that facilitate customized treatment and prevention strategies for individual patients. For example, in February 2024, the Personalized Medicine Coalition, a US-based hospital and healthcare organization, reported that the FDA approved 16 new personalized treatments for rare disease patients in 2023, up from six approvals in 2022. Therefore, the growing demand for personalized medicine is driving the expansion of the next-generation in vitro diagnostics (IVD) market.

Key players in the next-generation in vitro diagnostics (IVD) market are adopting strategic partnerships by collaborating with technology providers, research institutions, and healthcare organizations to accelerate innovation, improve diagnostic accuracy, and broaden access to advanced testing solutions for individuals, businesses, and governments. Strategic partnerships involve companies leveraging each other's strengths and resources to achieve shared benefits and success. For instance, in October 2024, Yourgene Health, a UK-based biotechnology company, partnered with Genetix, a Colombia-based human genetic diagnosis company, to introduce Colombia's first local non-invasive prenatal testing (NIPT) service. This initiative marks a significant advancement in prenatal care within the region, providing expectant parents with faster, more reliable, and cost-effective access to advanced genetic screening. The service employs Yourgene Health's IONA Nx NIPT Workflow, a comprehensive, CE-marked in vitro diagnostic (IVD) solution. This workflow is highly flexible and scalable, accommodating varying sample volumes, and enables Genetix to offer a quality-assured prenatal screening service throughout Colombia.

In February 2023, SD Biosensor Inc., a South Korea-based in-vitro diagnostics company, along with SJL Partners LLC, a South Korea-based investment firm, acquired Meridian Bioscience Inc. for $1.53 billion. Through this acquisition, SD Biosensor aims to leverage Meridian's expertise in diagnostic products and raw materials used in immunological and molecular tests across various applications. Meridian Bioscience Inc. is a US-based diagnostic company specializing in in vitro diagnostic enzymes.

Major players in the next-generation in vitro diagnostics (IVD) market are F Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Becton Dickinson and Company, Quest Diagnostics Incorporated, Grifols SA, Agilent Technologies Inc., Illumina Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., Revvity Inc., Exact Sciences Corporation, QIAGEN NV, DiaSorin SpA, Singular Genomics Systems Inc., Guardant Health Inc., Pacific Biosciences of California Inc., Transasia Bio-Medicals Ltd., Athena Dx, and J Mitra and Co Pvt Ltd.

North America was the largest region in the next-generation in vitro diagnostics (IVD) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in next-generation in vitro diagnostics (IVD) report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the next-generation in vitro diagnostics (IVD) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The next-generation in vitro diagnostics (IVD) market consists of revenues earned by entities providing services such as genomic testing services, molecular diagnostics services, and companion diagnostics. The market value includes the value of related goods sold by the service provider or included within the service offering. The next-generation in vitro diagnostics (IVD) market also includes sales of molecular diagnostics kits, proteomics-based diagnostic kits, and NGS sample preparation kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Next-Generation In Vitro Diagnostics (IVD) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on next-generation in vitro diagnostics (ivd) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for next-generation in vitro diagnostics (ivd) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The next-generation in vitro diagnostics (ivd) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Consumables; Instruments; Software
  • 2) By Type: Core Laboratory Diagnostics; Point-Of-Care Testing; Molecular Diagnostics
  • 3) By Application: Oncology Or Cancer; Infectious Diseases; Diabetes; Cardiology ; Other Applications
  • 4) By End-User: Hospitals And Clinics; Diagnostic Laboratories; Academic And Research Institutions; Other End Users
  • Subsgements:
  • 1) By Consumables: Barcode Labels; Radio Frequency Identification Tags; Specimen Bags and Tubes; Labeling Ribbons; Seals and Caps
  • 2) By Instruments: Barcode Scanners; Radio Frequency Identification Readers; Label Printers; Workstations and Terminals; Storage and Transport Monitoring Devices
  • 3) By Software: Laboratory Information Management Systems; Specimen Tracking Software Modules; Cloud-Based Tracking Software; Barcode and Radio Frequency Identification Integration Platforms; Mobile Applications for Specimen Tracking
  • Companies Mentioned: F Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; Abbott Laboratories; Becton Dickinson and Company; Quest Diagnostics Incorporated; Grifols SA; Agilent Technologies Inc.; Illumina Inc.; Sysmex Corporation; Bio-Rad Laboratories Inc.; Revvity Inc.; Exact Sciences Corporation; QIAGEN NV; DiaSorin SpA; Singular Genomics Systems Inc.; Guardant Health Inc.; Pacific Biosciences of California Inc.; Transasia Bio-Medicals Ltd.; Athena Dx; J Mitra and Co Pvt Ltd
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Next-Generation In Vitro Diagnostics (IVD) Market Characteristics

3. Next-Generation In Vitro Diagnostics (IVD) Market Trends And Strategies

4. Next-Generation In Vitro Diagnostics (IVD) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Next-Generation In Vitro Diagnostics (IVD) Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Next-Generation In Vitro Diagnostics (IVD) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Next-Generation In Vitro Diagnostics (IVD) Market Growth Rate Analysis
  • 5.4. Global Next-Generation In Vitro Diagnostics (IVD) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Next-Generation In Vitro Diagnostics (IVD) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Next-Generation In Vitro Diagnostics (IVD) Total Addressable Market (TAM)

6. Next-Generation In Vitro Diagnostics (IVD) Market Segmentation

  • 6.1. Global Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Consumables
  • Instruments
  • Software
  • 6.2. Global Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Core Laboratory Diagnostics
  • Point-Of-Care Testing
  • Molecular Diagnostics
  • 6.3. Global Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oncology Or Cancer
  • Infectious Diseases
  • Diabetes
  • Cardiology
  • Other Applications
  • 6.4. Global Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Clinics
  • Diagnostic Laboratories
  • Academic And Research Institutions
  • Other End Users
  • 6.5. Global Next-Generation In Vitro Diagnostics (IVD) Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Barcode Labels
  • Radio Frequency Identification Tags
  • Specimen Bags And Tubes
  • Labeling Ribbons
  • Seals And Caps
  • 6.6. Global Next-Generation In Vitro Diagnostics (IVD) Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Barcode Scanners
  • Radio Frequency Identification Readers
  • Label Printers
  • Workstations And Terminals
  • Storage And Transport Monitoring Devices
  • 6.7. Global Next-Generation In Vitro Diagnostics (IVD) Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Laboratory Information Management Systems
  • Specimen Tracking Software Modules
  • Cloud-Based Tracking Software
  • Barcode And Radio Frequency Identification Integration Platforms
  • Mobile Applications for Specimen Tracking

7. Next-Generation In Vitro Diagnostics (IVD) Market Regional And Country Analysis

  • 7.1. Global Next-Generation In Vitro Diagnostics (IVD) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Next-Generation In Vitro Diagnostics (IVD) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Next-Generation In Vitro Diagnostics (IVD) Market

  • 8.1. Asia-Pacific Next-Generation In Vitro Diagnostics (IVD) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Next-Generation In Vitro Diagnostics (IVD) Market

  • 9.1. China Next-Generation In Vitro Diagnostics (IVD) Market Overview
  • 9.2. China Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Next-Generation In Vitro Diagnostics (IVD) Market

  • 10.1. India Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Next-Generation In Vitro Diagnostics (IVD) Market

  • 11.1. Japan Next-Generation In Vitro Diagnostics (IVD) Market Overview
  • 11.2. Japan Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Next-Generation In Vitro Diagnostics (IVD) Market

  • 12.1. Australia Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Next-Generation In Vitro Diagnostics (IVD) Market

  • 13.1. Indonesia Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Next-Generation In Vitro Diagnostics (IVD) Market

  • 14.1. South Korea Next-Generation In Vitro Diagnostics (IVD) Market Overview
  • 14.2. South Korea Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Next-Generation In Vitro Diagnostics (IVD) Market

  • 15.1. Western Europe Next-Generation In Vitro Diagnostics (IVD) Market Overview
  • 15.2. Western Europe Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Next-Generation In Vitro Diagnostics (IVD) Market

  • 16.1. UK Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Next-Generation In Vitro Diagnostics (IVD) Market

  • 17.1. Germany Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Next-Generation In Vitro Diagnostics (IVD) Market

  • 18.1. France Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Next-Generation In Vitro Diagnostics (IVD) Market

  • 19.1. Italy Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Next-Generation In Vitro Diagnostics (IVD) Market

  • 20.1. Spain Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Next-Generation In Vitro Diagnostics (IVD) Market

  • 21.1. Eastern Europe Next-Generation In Vitro Diagnostics (IVD) Market Overview
  • 21.2. Eastern Europe Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Next-Generation In Vitro Diagnostics (IVD) Market

  • 22.1. Russia Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Next-Generation In Vitro Diagnostics (IVD) Market

  • 23.1. North America Next-Generation In Vitro Diagnostics (IVD) Market Overview
  • 23.2. North America Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Next-Generation In Vitro Diagnostics (IVD) Market

  • 24.1. USA Next-Generation In Vitro Diagnostics (IVD) Market Overview
  • 24.2. USA Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Next-Generation In Vitro Diagnostics (IVD) Market

  • 25.1. Canada Next-Generation In Vitro Diagnostics (IVD) Market Overview
  • 25.2. Canada Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Next-Generation In Vitro Diagnostics (IVD) Market

  • 26.1. South America Next-Generation In Vitro Diagnostics (IVD) Market Overview
  • 26.2. South America Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Next-Generation In Vitro Diagnostics (IVD) Market

  • 27.1. Brazil Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Next-Generation In Vitro Diagnostics (IVD) Market

  • 28.1. Middle East Next-Generation In Vitro Diagnostics (IVD) Market Overview
  • 28.2. Middle East Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Next-Generation In Vitro Diagnostics (IVD) Market

  • 29.1. Africa Next-Generation In Vitro Diagnostics (IVD) Market Overview
  • 29.2. Africa Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Next-Generation In Vitro Diagnostics (IVD) Market Competitive Landscape And Company Profiles

  • 30.1. Next-Generation In Vitro Diagnostics (IVD) Market Competitive Landscape
  • 30.2. Next-Generation In Vitro Diagnostics (IVD) Market Company Profiles
    • 30.2.1. F Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis

31. Next-Generation In Vitro Diagnostics (IVD) Market Other Major And Innovative Companies

  • 31.1. Grifols SA
  • 31.2. Agilent Technologies Inc.
  • 31.3. Illumina Inc.
  • 31.4. Sysmex Corporation
  • 31.5. Bio-Rad Laboratories Inc.
  • 31.6. Revvity Inc.
  • 31.7. Exact Sciences Corporation
  • 31.8. QIAGEN NV
  • 31.9. DiaSorin SpA
  • 31.10. Singular Genomics Systems Inc.
  • 31.11. Guardant Health Inc.
  • 31.12. Pacific Biosciences of California Inc.
  • 31.13. Transasia Bio-Medicals Ltd.
  • 31.14. Athena Dx
  • 31.15. J Mitra and Co Pvt Ltd

32. Global Next-Generation In Vitro Diagnostics (IVD) Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Next-Generation In Vitro Diagnostics (IVD) Market

34. Recent Developments In The Next-Generation In Vitro Diagnostics (IVD) Market

35. Next-Generation In Vitro Diagnostics (IVD) Market High Potential Countries, Segments and Strategies

  • 35.1 Next-Generation In Vitro Diagnostics (IVD) Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Next-Generation In Vitro Diagnostics (IVD) Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Next-Generation In Vitro Diagnostics (IVD) Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer